Only about a third of the $2.89 billion in aid money pledged to fight the Ebola virus in west Africa was actually delivered, according to an analysis published by the British Medical Journal.
The report pointed to delays in the international response since the first reports about the deadly outbreak in March 2014 and said that "this may have contributed to the ongoing spread of the disease".
WHO Has Appointed Bruce Aylward to Head Its Overall Response to the Ebola Outbreak
The World Health Organization (WHO) has appointed its assistant director-general Bruce Aylward to head its overall response to the deadly Ebola outbreak.
Advertisement
"Like the international response, contributions to fight the epidemic were slow to take off," said the report by Karen Grepin, assistant professor of global health policy at New York University.
The report, published on Tuesday, identified the United States as the top donor, saying it had disbursed $855 million (746 million euros) by December 31.
![Ebola Vaccine Trials Halted Due to Fall in New Ebola Cases]( "Ebola Vaccine Trials Halted Due to Fall in New Ebola Cases")
The clinical trials for a new Ebola vaccine in Liberia were halted due to a fall in new cases, informed Britain's Wellcome Trust.
It was followed by Britain, the World Bank, Germany, France and Microsoft co-founder Paul Allen, a US philanthropist who sent $55 million.
A total of $1.09 billion had been delivered by the end of 2014 -- around 38 percent of the total pledged.
The World Health Organization was first alerted to the current outbreak of the Ebola virus in March last year but only declared a public health emergency of international concern in August, the report said.
The first $500 million of aid only arrived in mid-October and the total reached $1.0 billion only in December, with Liberia being the single biggest recipient of aid ($882 million).
The report also said the World Bank had pledged $230 million but disbursed only $117 million, although it added that that the data did not cover loans to the affected countries.
"We need a mechanism to enable more rapid disbursement of funds to fight public health threats such as Ebola," the report said, adding that "existing contracting mechanisms are too slow".
Source: AFP
Ebola Vaccine Trials Halted Due to Fall in New Ebola Cases
The clinical trials for a new Ebola vaccine in Liberia were halted due to a fall in new cases, informed Britain's Wellcome Trust.
Advertisement
It was followed by Britain, the World Bank, Germany, France and Microsoft co-founder Paul Allen, a US philanthropist who sent $55 million.
A total of $1.09 billion had been delivered by the end of 2014 -- around 38 percent of the total pledged.
The World Health Organization was first alerted to the current outbreak of the Ebola virus in March last year but only declared a public health emergency of international concern in August, the report said.
The first $500 million of aid only arrived in mid-October and the total reached $1.0 billion only in December, with Liberia being the single biggest recipient of aid ($882 million).
The report also said the World Bank had pledged $230 million but disbursed only $117 million, although it added that that the data did not cover loans to the affected countries.
"We need a mechanism to enable more rapid disbursement of funds to fight public health threats such as Ebola," the report said, adding that "existing contracting mechanisms are too slow".
Source: AFP
African Union criticized Over Poor Record in the Early Stages of Ebola Epidemic
As Africa's leader meet at the 54-nation African Union (AU) summit in Ethiopia, Addis Ababa, to discuss the Ebola crisis, expectations of firm action will be tempered by criticism.
Advertisement
 Large-Scale Trials of Two Ebola Vaccines Begins in LiberiaThe first large-scale trials of two Ebola vaccines, GlaxoSmithKline's Chad3-EBO-Z and Merck and Newlink's rVSV-ZEBOV, has begun in Liberia at the Redemption Hospital in the capital Monrovia. | Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
The Pakistan Ministry has announced the commencement of a nationwide polio vaccination campaign beginning on October 2, aiming to immunize more children.
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
